Published in Biochim Biophys Acta on February 27, 1997
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50
BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease. Mol Neurodegener (2012) 1.11
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol Life Sci (2010) 0.89
Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. Biomed Res Int (2014) 0.87
Carnosine: can understanding its actions on energy metabolism and protein homeostasis inform its therapeutic potential? Chem Cent J (2013) 0.87
Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. Antioxid Redox Signal (2013) 0.83
Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide. J Clin Immunol (2010) 0.83
Isolation, purification and characterization of histidino-threosidine, a novel Maillard reaction protein crosslink from threose, lysine and histidine. Arch Biochem Biophys (2007) 0.80
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain. J Neural Transm (Vienna) (2006) 0.80
The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease. PLoS One (2015) 0.78
Anti-aggregating effect of the naturally occurring dipeptide carnosine on aβ1-42 fibril formation. PLoS One (2013) 0.78
Carnosine and Related Peptides: Therapeutic Potential in Age-Related Disorders. Aging Dis (2015) 0.78
Aminoguanidine changes hippocampal expression of apoptosis-related genes, improves passive avoidance learning and memory in streptozotocin-induced diabetic rats. Cell Mol Neurobiol (2013) 0.77
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant? Dialogues Clin Neurosci (2003) 0.76
Differential effects of glycation on protein aggregation and amyloid formation. Front Mol Biosci (2014) 0.76
Crystallization and preliminary X-ray data analysis of beta-alanine synthase from Drosophila melanogaster. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75
Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts. Front Mol Biosci (2016) 0.75
Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene (1995) 13.86
Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res (1994) 10.72
Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (1985) 9.73
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res (1999) 6.39
Beyond 'substantial equivalence'. Nature (1999) 5.91
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem (1996) 5.42
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature (1982) 4.44
Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc Natl Acad Sci U S A (1983) 4.38
The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J (1989) 4.27
The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J (1987) 4.00
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53
A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer (2000) 3.49
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res (1986) 3.21
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res (1985) 3.09
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int (1996) 2.98
Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. EMBO J (1989) 2.98
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. Pharmacopsychiatry (2011) 2.91
Ultrastructure of a periodic protein layer in the outer membrane of Escherichia coli. J Cell Biol (1977) 2.89
The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell (1989) 2.84
Patient communication during cataract surgery. Eye (Lond) (2004) 2.83
Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe. Lancet (1998) 2.77
Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila. EMBO J (1988) 2.70
Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J (1995) 2.67
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res (2001) 2.65
Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem Biol (1998) 2.64
Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol (1971) 2.51
CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51
Falls from heights: a childhood epidemic in an urban area. Am J Public Health (1971) 2.35
Induction of c-fos during myelomonocytic differentiation and macrophage proliferation. Nature (1985) 2.34
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett (1994) 2.27
A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr (2001) 2.25
The structure of the RNA binding site of ribosomal proteins S8 and S15. J Biol Chem (1979) 2.24
Alternative splicing of human cyclin E. J Cell Sci (1994) 2.20
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett (1995) 2.19
Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A (1985) 2.18
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett (1994) 2.17
Inducible regulatory elements in the human cyclin D1 promoter. Oncogene (1994) 2.16
Justification of the 4-mmol/l lactate threshold. Int J Sports Med (1985) 2.15
Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol (1983) 2.14
KDR receptor: a key marker defining hematopoietic stem cells. Science (1999) 2.13
Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer (1988) 2.11
Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm (1988) 2.10
Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. EMBO J (1983) 2.08
Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08
Drug assay using antibody mimics made by molecular imprinting. Nature (1993) 2.04
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
Specificity and localization of the hepatitis B virus-associated protein kinase. J Virol (1982) 2.00
trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. Cell (1989) 2.00
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem (1985) 1.99
Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J (1990) 1.97
Organization of the human serotonin transporter gene. J Neural Transm Gen Sect (1994) 1.97
Radiation hazards from Sellafield. Lancet (1993) 1.94
Revising the preventive paradox: the Swiss case. Addiction (2001) 1.92
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm (Vienna) (1998) 1.90
Cell cycle regulation of E2F site occupation in vivo. Science (1996) 1.90
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm (Vienna) (2004) 1.89
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. J Neural Transm (1985) 1.89
Chronic spinal pain syndromes: a clinical pilot trial comparing acupuncture, a nonsteroidal anti-inflammatory drug, and spinal manipulation. J Manipulative Physiol Ther (1999) 1.88
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. Eur J Clin Pharmacol (1992) 1.86
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84
An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation. EMBO J (1994) 1.83
Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages. Cell (1987) 1.83
Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Proc Natl Acad Sci U S A (1987) 1.82
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol (2001) 1.81
Incorporation of [18O]water into 4-hydroxybenzoic acid in the reaction of 4-chlorobenzoate dehalogenase from pseudomonas spec. CBS 3. Biochem Biophys Res Commun (1984) 1.80
Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene (1994) 1.77
Purification and some properties of 2-halobenzoate 1,2-dioxygenase, a two-component enzyme system from Pseudomonas cepacia 2CBS. J Bacteriol (1992) 1.76
Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay. Methods Enzymol (1983) 1.76
Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex. Nature (1989) 1.74
Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding. Nature (1990) 1.74
Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene (1994) 1.73
Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J (1985) 1.73
Endothelial-like cells derived from human CD14 positive monocytes. Differentiation (2000) 1.73
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem (1991) 1.70
Eutrophication causes speciation reversal in whitefish adaptive radiations. Nature (2012) 1.69
Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas. Ann Oncol (2011) 1.66
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication. J Neural Transm (Vienna) (1997) 1.65
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry (2004) 1.64
[Ampicillin--a semi-synthetic penicillin in pregnancy, the newborn and premature period]. Monatsschr Kinderheilkd (1968) 1.64
Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther (2001) 1.63
Multimodal imaging demonstrates concomitant changes in bone and cartilage after destabilisation of the medial meniscus and increased joint laxity. Osteoarthritis Cartilage (2010) 1.63
Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J (1984) 1.63
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil. J Neural Transm (1975) 1.62
The synthesis of sialylated oligosaccharides using a CMP-Neu5Ac synthetase/sialyltransferase fusion. Nat Biotechnol (1998) 1.61
Integration of transfected LTR sequences into the c-raf proto-oncogene: activation by promoter insertion. EMBO J (1985) 1.60
Electromagnetic interference of pacemakers by mobile phones. Pacing Clin Electrophysiol (1996) 1.60